Palmer, D H <br/><br/>
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.  [electronic resource] 

 -  Gene therapy  Aug 2005 
 - 1187-97 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0969-7128 
<br/><br/><label>Standard No.: </label>10.1038/sj.gt.3302510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Aziridines--administration & dosage<br/>Cell Line, Tumor<br/>Enzyme Activation<br/>Genetic Therapy--methods<br/>Genetic Vectors--administration & dosage<br/>Humans<br/>NF-kappa B--metabolism<br/>Neoplasms--metabolism<br/>Nitroreductases--genetics<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Prodrugs--administration & dosage<br/>Signal Transduction<br/>Virus Replication